Canada Veterinary Ocular Medicine Market by Supplementary Medications (2024–2032)

The Canada veterinary ocular medicine market demonstrated measurable progress in ***, as immunomodulators recorded USD ***.*** thousand and lubricants & artificial tears reached USD ***.*** thousand. The steady contribution of anti-glaucoma agents at USD ***.*** thousand reflected consistent clinical utilisation in managing ocular disorders among companion animals. This performance underscores the market’s early emphasis on expanding therapeutic diversity and strengthening product portfolios across specialised ophthalmic categories. In ***, immunomodulators are estimated to reach USD ***.*** thousand, while lubricants & artificial tears are expected to advance to USD ***.*** thousand, signalling continued integration into advanced treatment practices. By ***, lubricants & artificial tears are projected to reach USD ***.*** thousand, and immunomodulators are anticipated to attain USD ***.*** thousand, outlining a sustained upward trajectory. The Canadian Veterinary Ocular Medicine Ma...